塞力医疗
(603716)
| 流通市值：26.57亿 | | | 总市值：26.57亿 |
| 流通股本：1.91亿 | | | 总股本：1.91亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 287,429,208.68 | 1,810,681,362.15 | 1,420,111,454.42 | 975,687,565.49 |
| 营业收入 | 287,429,208.68 | 1,810,681,362.15 | 1,420,111,454.42 | 975,687,565.49 |
| 二、营业总成本 | 309,686,560.92 | 1,891,348,685.68 | 1,444,210,701.93 | 980,796,893.37 |
| 营业成本 | 219,586,699.65 | 1,478,798,942.33 | 1,137,695,865.9 | 789,547,057.5 |
| 税金及附加 | 1,529,356.25 | 8,222,328.95 | 5,425,670.16 | 3,666,139.99 |
| 销售费用 | 24,063,391.05 | 127,591,199.13 | 100,018,355.49 | 60,837,700.23 |
| 管理费用 | 38,615,676.45 | 174,918,945.83 | 122,836,376.29 | 76,861,903.67 |
| 研发费用 | 13,980,853.82 | 46,742,915.06 | 31,457,970.43 | 20,165,973.96 |
| 财务费用 | 11,910,583.7 | 55,074,354.38 | 46,776,463.66 | 29,718,118.02 |
| 其中:利息费用 | 11,804,733.65 | 57,681,022.85 | 50,580,751.84 | 34,546,906.45 |
| 其中:利息收入 | 364,360.32 | 3,838,688.09 | 5,951,084.51 | 5,195,150.25 |
| 加:投资收益 | 11,670,780.29 | -65,216,566.55 | -47,577,734.26 | -1,810,379.62 |
| 资产处置收益 | 757,346.65 | -7,620,084.92 | 281,262.2 | 212,832.42 |
| 资产减值损失(新) | -80,168.05 | -25,597,401.25 | -465,161.42 | -358,270.71 |
| 信用减值损失(新) | -1,792,894.56 | 34,605,768.01 | 19,536,326 | 19,594,697.12 |
| 其他收益 | 254,413.66 | 2,701,532.6 | 2,140,735.08 | 1,897,216.74 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -11,447,874.25 | -141,794,075.64 | -50,183,819.91 | 14,426,768.07 |
| 加:营业外收入 | 107,542.15 | 1,383,928.08 | 1,428,624.25 | 188,693.24 |
| 减:营业外支出 | 83,782.29 | 7,886,710.8 | 1,539,192.52 | 1,494,703.49 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -11,424,114.39 | -148,296,858.36 | -50,294,388.18 | 13,120,757.82 |
| 减:所得税费用 | 341,554.85 | 45,092,718.78 | -16,781,741.35 | 4,772,579.22 |
| 六、净利润 | -11,765,669.24 | -193,389,577.14 | -33,512,646.83 | 8,348,178.6 |
| 持续经营净利润 | -11,765,669.24 | -193,389,577.14 | -33,512,646.83 | 8,348,178.6 |
| 归属于母公司股东的净利润 | -14,320,949.69 | -209,239,667.57 | -56,025,062.27 | -4,772,497.51 |
| 少数股东损益 | 2,555,280.45 | 15,850,090.43 | 22,512,415.44 | 13,120,676.11 |
| (一)基本每股收益 | -0.07 | -1.09 | -0.28 | -0.02 |
| (二)稀释每股收益 | -0.07 | -1.09 | -0.28 | -0.02 |
| 八、其他综合收益 | -53,613.64 | 6,075,434.7 | -10,669,820.47 | -7,040,616.55 |
| 归属于母公司股东的其他综合收益 | -53,613.64 | 6,075,434.7 | -10,669,820.47 | -7,040,616.55 |
| 九、综合收益总额 | -11,819,282.88 | -187,314,142.44 | -44,182,467.3 | 1,307,562.05 |
| 归属于母公司股东的综合收益总额 | -14,374,563.33 | -203,164,232.87 | -66,694,882.74 | -11,813,114.06 |
| 归属于少数股东的综合收益总额 | 2,555,280.45 | 15,850,090.43 | 22,512,415.44 | 13,120,676.11 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |